Dr. Masiukiewicz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
20 York St
Ynhh - West Pavilion, 2nd Floor
New Haven, CT 06510Phone+1 203-785-4081Fax+1 203-785-3833
Education & Training
- Yale-New Haven Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1996 - 1998
- UMass Chan Medical SchoolResidency, Internal Medicine, 1993 - 1996
- Medical University of WarsawClass of 1985
Certifications & Licensure
- CT State Medical License 1997 - 2025
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- 565 citationsAssociation of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: A Meta-analysis.Darren K. McGuire, Weichung Shih, Francesco Cosentino, Bernard Charbonnel, David Z.I. Cherney
JAMA Cardiology. 2021-02-01 - 446 citationsCardiovascular efficacy and safety of bococizumab in high-risk patientsPaul M. Ridker, James H. Revkin, Pierre Amarenco, Robert Brunell, Madelyn Curto
The New England Journal of Medicine. 2017-04-20 - 1592 citationsOral Apixaban for the Treatment of Acute Venous ThromboembolismGiancarlo Agnelli, Harry R. Buller, Alexander T. Cohen, Madelyn Curto, Alexander Gallus
The New England Journal of Medicine. 2013-08-28
Journal Articles
- Association of SGLT2 Inhibitors with Cardiovascular and Kidney Outcomes in Patients with Type 2 DiabetesDarren K Mcguire, Samuel Dagogo-Jack, Urszula Masiukiewicz, JAMA Cardiology
- Cardiovascular Outcomes with Ertugliflozin in Type 2 DiabetesSamuel Dagogo-Jack, Urszula Masiukiewicz, Robert Frederich, Darren K Mcguire, The New England Journal of Medicine
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: